RE:CLARIFICATION NEEDED FROM CO.To be clear. The company has stated that Metformin does activate Rutherin as demonstrated in a preclinical study. Does activate....not potentially. Also, Rutherin is not yet FDA approved so it feels like after the 57M share dilution passes us by when that many warrants expire. The approval of Rutherin will also have been preceded with a list of uses including the subject of the study (NMIBC), that will add to the seemingly longer and longer list of cancer indications Rutherin can be used off label for. Compounding the dollar value of this drug upon approval. A perfect storm in the making.